Anti-Cancer Agents in Medicinal Chemistry

(Formerly Current Medicinal Chemistry - Anti-Cancer Agents)


Simone Carradori
Department of Pharmacy
“G. d’Annunzio” University of Chieti-Pescara

Personal Subscription
Become EABM
Become Reviewer
Call for Editor
Volume: 7 Issue: 2, March

Acridine and Acridone Derivatives, Anticancer Properties and Synthetic Methods: Where Are We Now?

Volume:7   Issue: 2
Pp: 139-169
Philippe Belmont, Johann Bosson, Thomas Godet and Martin Tiano
DOI: 10.2174/187152007780058669
Published on: 01 March, 2012

In Silico Design of Protein Kinase Inhibitors: Successes and Failures

Volume:7   Issue: 2
Pp: 171-188
Galina G. Dubinina, Oleksandr O. Chupryna, Maxim O. Platonov, Petro O. Borisko, Galina V. Ostrovska, Andriy O. Tolmachov and Alexander A. Shtil
DOI: 10.2174/187152007780058704
Published on: 01 March, 2012

Recent Progress in Discovery and Development of Antimitotic Agents

Volume:7   Issue: 2
Pp: 189-208
Alex Kiselyov, Konstantin V. Balakin, Sergey E. Tkachenko, Nikolay Savchuk and Alexandre V. Ivachtchenko
DOI: 10.2174/187152007780058650
Published on: 01 March, 2012

Meta-Analysis of Anticancer Drug Structures - Significance of Their Polar Allylic Moieties

Volume:7   Issue: 2
Pp: 209-222
Norman S. Radin
DOI: 10.2174/187152007780058696
Published on: 01 March, 2012

Vascular Endothelial Growth Factor (VEGF) Inhibition - A Critical Review

Volume:7   Issue: 2
Pp: 223-245
Irina Sousa Moreira, Pedro Alexandrino Fernandes and Maria Joao Ramos
DOI: 10.2174/187152007780058687
Published on: 01 March, 2012

Antitumor Carbazoles

Volume:7   Issue: 2
Pp: 247-267
Christian Asche and Martine Demeunynck
DOI: 10.2174/187152007780058678
Published on: 01 March, 2012